Pulsing Addition to Modulated Electro-Hyperthermia

Overview

Journal Bioengineering (Basel)

Date 2024 Jul 27

PMID 39061807

Authors

Andras Szasz

Affiliations

Soon will be listed here.

Abstract

Numerous preclinical results have been verified, and clinical results have validated the advantages of modulated electro-hyperthermia (mEHT). This method uses the nonthermal effects of the electric field in addition to thermal energy absorption. Modulation helps with precisely targeting and immunogenically destroying malignant cells, which could have a vaccination-like abscopal effect. A new additional modulation (high-power pulsing) further develops the abilities of the mEHT. My objective is to present the advantages of pulsed treatment and how it fits into the mEHT therapy. Pulsed treatment increases the efficacy of destroying the selected tumor cells; it is active deeper in the body, at least tripling the penetration of the energy delivery. Due to the constant pulse amplitude, the dosing of the absorbed energy is more controllable. The induced blood flow for reoxygenation and drug delivery is high enough but not as high as increasing the risk of the dissemination of malignant cells. The short pulses have reduced surface absorption, making the treatment safer, and the increased power in the pulses allows the reduction of the treatment time needed to provide the necessary dose.

References

Sorrell R, Muhlenfeld J, Moffett J, Stevens G, Kesten S . Evaluation of pulsed electromagnetic field therapy for the treatment of chronic postoperative pain following lumbar surgery: a pilot, double-blind, randomized, sham-controlled clinical trial. J Pain Res. 2018; 11:1209-1222. PMC: 6018879. DOI: 10.2147/JPR.S164303. View

Ishikawa T, Kokura S, Sakamoto N, Ando T, Imamoto E, Hattori T . Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. Int J Hyperthermia. 2012; 28(7):597-604. DOI: 10.3109/02656736.2012.695428. View

Larson S . Positron emission tomography-based molecular imaging in human cancer: exploring the link between hypoxia and accelerated glucose metabolism. Clin Cancer Res. 2004; 10(7):2203-4. DOI: 10.1158/1078-0432.ccr-0002-4. View

Semenza G . Tumor metabolism: cancer cells give and take lactate. J Clin Invest. 2008; 118(12):3835-7. PMC: 2582934. DOI: 10.1172/JCI37373. View

Datta N, Bose A, Kapoor H, Gupta S . Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia. 1990; 6(3):479-86. DOI: 10.3109/02656739009140944. View

Otsuka T, Yonezawa M, Kamiyama F, Matsushita Y, Matsui N . Results of surgery and radio-hyperthermo-chemotherapy for patients with soft-tissue sarcoma. Int J Clin Oncol. 2001; 6(5):253-8. DOI: 10.1007/pl00012114. View

Lu C, Chen W, Hsieh C, Kuo Y, Chao C . Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells. PLoS One. 2019; 14(5):e0217676. PMC: 6544372. DOI: 10.1371/journal.pone.0217676. View

Andocs G, Renner H, Balogh L, Fonyad L, Jakab C, Szasz A . Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Strahlenther Onkol. 2009; 185(2):120-6. DOI: 10.1007/s00066-009-1903-1. View

Huilgol N, Gupta S, Sridhar C . Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther. 2011; 6(4):492-6. DOI: 10.4103/0973-1482.77101. View

10.

Forika G, Balogh A, Vancsik T, Zalatnai A, Petovari G, Benyo Z . Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro. Int J Mol Sci. 2020; 21(14). PMC: 7404126. DOI: 10.3390/ijms21145100. View

11.

Kotnik T, Miklavcic D . Theoretical evaluation of the distributed power dissipation in biological cells exposed to electric fields. Bioelectromagnetics. 2000; 21(5):385-94. View

12.

Nagata Y, Hiraoka M, Nishimura Y, Masunaga S, Mitumori M, Okuno Y . Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys. 1997; 38(2):359-65. DOI: 10.1016/s0360-3016(96)00625-6. View

13.

Tsang Y, Huang C, Yang K, Chi M, Chiang H, Wang Y . Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy. BMC Cancer. 2015; 15:708. PMC: 4608323. DOI: 10.1186/s12885-015-1690-2. View

14.

Cloutier M, Wang E . Dynamic modeling and analysis of cancer cellular network motifs. Integr Biol (Camb). 2011; 3(7):724-32. DOI: 10.1039/c0ib00145g. View

15.

Lee I, Imanaka M, Modahl E, Torres-Ocampo A . Lipid Raft Phase Modulation by Membrane-Anchored Proteins with Inherent Phase Separation Properties. ACS Omega. 2019; 4(4):6551-6559. PMC: 6547621. DOI: 10.1021/acsomega.9b00327. View

16.

Agus D, Alexander J, Arap W, Ashili S, Aslan J, Austin R . A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep. 2013; 3:1449. PMC: 3636513. DOI: 10.1038/srep01449. View

17.

Szasz A . Heterogeneous Heat Absorption Is Complementary to Radiotherapy. Cancers (Basel). 2022; 14(4). PMC: 8870118. DOI: 10.3390/cancers14040901. View

18.

Kakehi M, Ueda K, Mukojima T, Hiraoka M, Seto O, Akanuma A . Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia. 1990; 6(4):719-40. DOI: 10.3109/02656739009140820. View

19.

Ohguri T, Imada H, Narisada H, Yahara K, Morioka T, Nakano K . Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results. Int J Hyperthermia. 2009; 25(2):160-7. DOI: 10.1080/02656730802610357. View

20.

Heikela M, Vattulainen I, Hyvonen M . Atomistic simulation studies of cholesteryl oleates: model for the core of lipoprotein particles. Biophys J. 2006; 90(7):2247-57. PMC: 1403197. DOI: 10.1529/biophysj.105.069849. View